Shield Therapeutics plc (AIM:STX)
London · Delayed Price · Currency is GBP · Price in GBX 6.05
+0.03 (0.50%)
Oct 1, 2026, 4:39 PM GMT
Shield Therapeutics Market Cap
Shield Therapeutics has a market cap or net worth of 64.73 million as of October 1, 2026. Its market cap has decreased by -17.05% in one year.
Market Cap
64.73M
Enterprise Value
77.21M
Revenue
44.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.05
ChartMarket Cap Chart
Since February 26, 2016, Shield Therapeutics's market cap has decreased from 169.77M to 64.73M, a decrease of -61.87%. That is a compound annual growth rate of -8.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 64.73M | -38.11% |
| Dec 31, 2025 | 104.59M | 395.31% |
| Dec 31, 2024 | 21.12M | -59.70% |
| Dec 29, 2023 | 52.40M | 186.53% |
| Dec 30, 2022 | 18.29M | -80.96% |
| Dec 31, 2021 | 96.06M | 28.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Haleon | 29.69B |
| Hikma Pharmaceuticals | 3.38B |
| HUTCHMED (China) | 1.87B |
| Allergy Therapeutics | 300.80M |
| ECO Animal Health Group | 66.40M |
| Provexis | 20.53M |
| Hellenic Dynamics | 1.32M |
| Chill Brands Group | 915.12K |